Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

204 ARTÍCULOS , VIENDO DEL 61 AL 75

Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau

Lafirdeen ASM, Cognat E, Sabia S, Hourregue C, Lilamand M, Dugravot A, Bouaziz-Amar E, Laplanche JL, Hugon J, Singh-Manoux A, Paquet C, Dumurgier J.

PLoS One. 2019 May 14;14(5):e0217026. doi: 10.1371/journal.pone.0217026. eCollection 2019.

CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD

Blennow K, Diaz-Lucena D, Zetterberg H, Villar-Pique A, Karch A, Vidal E, Hermann P, Schmitz M, Ferrer Abizanda I, Zerr I, Llorens F.

J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):846-853. doi: 10.1136/jnnp-2018-320155. Epub 2019 May 16.

Definition and quantification of six immune- and neuroregulatory serum proteins in healthy and demented elderly

Schipke CG, Günter O, Weinert C, Scotton P, Sigle JP, Kallarackal J, Kabelitz D, Finzen A, Feuerhelm-Heidl A.

Neurodegener Dis Manag. 2019 Aug;9(4):193-203. doi: 10.2217/nmt-2019-0003. Epub 2019 May 17.

Biomarkers for Alzheimer's Disease

Guzman-Martinez L, Maccioni RB, Farías GA, Fuentes P, Navarrete LP.

Curr Alzheimer Res. 2019;16(6):518-528. doi: 10.2174/1567205016666190517121140.

Alzheimer's disease: Making the point

Bernardini S, Zima T.

Clin Biochem. 2019 Oct;72:1-2. doi: 10.1016/j.clinbiochem.2019.05.007. Epub 2019 May 21.

Associations of AD Biomarkers and Cognitive Performance with Nutritional Status: The NUDAD Project

Doorduijn AS, Visser M, van de Rest O, Kester MI, de Leeuw FA, Boesveldt S, Fieldhouse JLP, van den Heuvel EGHM, Teunissen CE, Scheltens P, van der Flier WM, de van der Schueren MAE.

Nutrients. 2019 May 23;11(5):1161. doi: 10.3390/nu11051161.

A Comparative Analysis of the Treatment of Decision-Making by or for Patients with Neurodegenerative Diseases in Four Legal Jurisdictions

Guzik-Makaruk EM, Pływaczewski EW, Laskowska K, Filipkowski W, Jurgielewicz-Delegacz E, Mroczko P.

J Alzheimers Dis. 2019;70(1):1-10. doi: 10.3233/JAD-190259.

What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France

Cognat E, Mouton Liger F, Troussière AC, Wallon D, Dumurgier J, Magnin E, Duron E, Gabelle A, Croisile B, de la Sayette V, Jager A, Blanc F, Bouaziz-Amar E, Miguet-Alfonsi C, Quillard M, Schraen S, Philippi N, Beaufils E, Pasquier F, Hannequin D, Robert P, Hugon J, Paquet C; ePLM network.

BMJ Open. 2019 May 30;9(5):e026380. doi: 10.1136/bmjopen-2018-026380.

Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid

Yang T, Dang Y, Ostaszewski B, Mengel D, Steffen V, Rabe C, Bittner T, Walsh DM, Selkoe DJ.

Ann Neurol. 2019 Aug;86(2):215-224. doi: 10.1002/ana.25513. Epub 2019 Jun 22.

Neuroimaging Biomarkers for Alzheimer's Disease

Márquez F, Yassa MA.

Mol Neurodegener. 2019 Jun 7;14(1):21. doi: 10.1186/s13024-019-0325-5.

Blood-based diagnostics of Alzheimer's disease

Penner G, Lecocq S, Chopin A, Vedoya X, Lista S, Vergallo A, Lejeune FX, Hampel H.

Expert Rev Mol Diagn. 2019 Jul;19(7):613-621. doi: 10.1080/14737159.2019.1626719. Epub 2019 Jun 8.

Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review

Gleerup HS, Hasselbalch SG, Simonsen AH.

Dis Markers. 2019 May 2;2019:4761054. doi: 10.1155/2019/4761054. eCollection 2019.

The standardization of cerebrospinal fluid markers and neuropathological diagnoses brings to light the frequent complexity of concomitant pathology in Alzheimer's disease: The next challenge for biochemical markers?

Fenouil T, Fourier A, Quadrio I, Streichenberger N, Bernardini S, Zima T, Perret-Liaudet A, Meyronet D.

Clin Biochem. 2019 Oct;72:15-23. doi: 10.1016/j.clinbiochem.2019.06.004. Epub 2019 Jun 10.

Salivary biological biomarkers for Alzheimer's disease

Liang D, Lu H.

Arch Oral Biol. 2019 Sep;105:5-12. doi: 10.1016/j.archoralbio.2019.06.004. Epub 2019 Jun 11.

Putting the New Alzheimer Disease Amyloid, Tau, Neurodegeneration (AT[N]) Diagnostic System to the Test

Wolk D, Salloway S, Dickerson B.

JAMA. 2019 Jun 18;321(23):2289-2291. doi: 10.1001/jama.2019.7534.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias